Concure Oncology
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3010 77th Ave SE Ste 206, Mercer Island,...Phone Number
(206) 275-3000Website
www.concureoncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Concure Oncology
Concure Oncology specializes in developing medical devices for early-stage breast cancer treatment and related services. It o0ffers technology, protocol, and equipment used by medical partners to perform the Breast Microseed Treatment (BMT), its early-stage, post lumpectomy breast cancer procedure. BMT combines a medical device, technology, and treatment procedure to deliver radiation therapy to patients with early-stage breast cancer.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Concure Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Concure Oncology recently announced quarterly report
Check out if Concure Oncology is spiking on competitors!
Check if Concure Oncology has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Concure Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Concure Oncology launches new products
Funding: Get notified immidiatlly once Concure Oncology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Concure Oncology
Click to see if Concure Oncology had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Concure Oncology as Masked Content
Find 3 more new buyers
Compare Similar Companies to Concure Oncology
Compare insights from companies similar to Concure Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Concure Oncology
<$5M
11-50
Private
$7.6M
2014
N/A
Company Profile Activity
Activity Insights
Concure Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Concure Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Concure Oncology.
Concure Oncology financials insights
Gather financial insights about Concure Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$500K
2016
Debt
$1.7M
2017
Debt
$825K
2020
Multiple Rounds
$4.7M
Concure Oncology Tech Stack
A closer look at the technologies used by Concure Oncology
Most Recent Scoops
Funding
Lateral Move
Executive Move
Executive Move
Executive Moves
Funding
Concure Oncology has received an SBA PPP loan for $150,000-350,000 from KeyBank National Association, supporting the retention of 11 jobs.
Funding
Funding
Concure Oncology News & Media
Tech Moves: Smartsheet CFO joins Auth0 board; Outreach opens NYC office; Concure Oncology adds CEO; and more
— Smartsheet CFO Jennifer Ceran joined the board of Bellevue, Wash.-based identity management provider Auth0. Last month, Smartsheet announced Ceran will retire after transitioning to a successor. She was previously an executive at Box, eBay and Cisco. “The opportunity to serve on Auth0’s Board represents a highlight in my career and one that I am very excited to dive into. Auth0’s success and future potential are undeniable,” said Ceran. Auth0 also added three new executives to iConcure Oncology Names Scott Armstrong as New Chief Executive Officer
SEATTLE, April 23, 2020 /PRNewswire/ -- Concure Oncology, which eases the burden for women facing early-stage breast cancer by providing an innovative new kind of radiation treatment option, announced its hiring of Scott Armstrong as its Chief Executive Officer. Armstrong joins Concure...Concure Oncology raises $2.5M for breast cancer treatment that fights tumors with radioactive seeds
Concure Oncology has raised $2.5 million in new capital for breast cancer treatment that uses radioactive seeds to prevent tumors from growing. With the new funding, announced last week, the Mercer Island-based startup has now secured more than $12 million with the most recent contribution coming from nearly 25 investors, including Chris Ackerley, managing director at Ackerley Partners, and Jeff Wright, chair of the Space Needle’s board. This new round of funding aims to doubleConcure Oncology Raises $2.5M in Funding
Concure Oncology, a Mercer Island, Wash.-based provider of radiation treatment options for women facing early-stage breast cancer, secured $2.5m in funding. Backers were not disclosed. The company intends to use the funds to double its field sales organization and focus on training new clinicians across the country. Led by a nationally-recognized team of leaders from […] The post Concure Oncology Raises $2.5M in Funding appeared first on FinSMEs.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Concure Oncology
Sign Up For FreeTo access detailed company insights
Concure Oncology specializes in developing medical devices for early-stage breast cancer treatment and related services. It o0ffers technology, protocol, and equipment used by medical partners to perform the Breast Microseed Treatment (BMT), its early-stage, post lumpectomy breast cancer procedure. BMT combines a medical device, technology, and tre... Read More
